Fulgent Genetics Inc.

NASDAQ: FLGT · Real-Time Price · USD
21.38
-0.19 (-0.88%)
At close: Aug 20, 2025, 3:59 PM
21.38
0.00%
After-hours: Aug 20, 2025, 04:10 PM EDT

Fulgent Genetics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-19.26M -11.9M -6.19M -15.46M -8.71M -13.46M -128.15M -13.47M -11.59M -15.85M -24.08M 1.34M 11.1M 153.56M 103.68M 122.22M 79.65M 200.69M
Depreciation & Amortization
6.05M 5.92M 6.19M 5.92M 6.15M 6.66M 6.53M 6.42M 6.31M 6.88M 9.8M 9.82M 8.35M 4.7M 3.49M 3.17M 2.42M 1.92M
Stock-Based Compensation
10.04M 10.55M 10.41M 10.92M 11.63M 11.52M 11.43M 10.9M 10.32M 10.27M 10.02M 8.97M 8.03M 5.62M 5.02M 4.37M 3.53M 2.96M
Other Working Capital
n/a -4.61M 30.32M -3.02M -1.55M 3.67M 15.31M 3.46M 843K -7.48M -28.38M -11.62M -46.92M 45.63M -15.84M -2.85M 20.86M 4.2M
Other Non-Cash Items
-26.76M -9.01M -1.22M -12.21M 23.22M 21.8M 114.38M -1.54M -668K 791K 9.76M 9.12M 9.84M 14.74M 8.07M 3.95M 935K 3.01M
Deferred Income Tax
-250K 4K -364K -2.36M -457K -557K 502K 19.1M -3.22M -5.2M 4.66M 2.8M -1.62M -5.01M -1.42M -3.49M -2.24M -690K
Change in Working Capital
n/a n/a 16.19M -2.33M -2.58M 4.91M 10.23M -11.18M 8.58M -4.79M 23.04M -11.28M -24.56M 14.82M -41.75M 21.97M -8.18M 25.29M
Operating Cash Flow
-30.17M -4.43M 25.02M -15.51M 4.29M 7.27M 14.93M 10.24M 9.74M -7.91M 33.21M 20.78M 11.13M 188.41M 77.09M 152.2M 76.11M 233.18M
Capital Expenditures
-6.83M -4.72M -3.78M -19.54M -12.94M -4.06M -3.11M -4.92M -12.14M -2.03M 5.28M -5.43M -3.26M -15.36M -6.01M -3.4M -2.94M -11.49M
Cash Acquisitions
n/a n/a n/a -275K 17K 258K -64K 22K 220K 198K -44.92M 222K -137.75M -10M -18.51M -43.36M -18.51M 13K
Purchase of Investments
n/a n/a -98.21M -115.38M -63.09M -195.74M -148.31M -93.06M -106.61M -143.93M -160.72M -11.78M -115.36M -145.13M -186.55M -119.13M -205.34M -219.47M
Sales Maturities Of Investments
60.23M 32.45M 74.53M 143.86M 83.32M 152.35M 175.75M 118.04M 117.44M 141.41M 107.59M 61.28M 42.67M 161.17M 52.27M 131.09M 71.78M 14.46M
Other Investing Acitivies
n/a 2K n/a 313K 20.25M 258K 27.77M 25M 11.05M -2.32M 172K 49.72M 4K 10.01M 18.55M 9K -18.51M 13K
Investing Cash Flow
53.4M 27.73M -27.45M 8.98M 7.3M -47.19M 24.27M 20.08M -1.1M -4.35M -92.6M 44.29M -213.69M 688K -140.26M -34.79M -155M -216.49M
Debt Repayment
n/a -606K -136K -136K -602K -900K 13.03M -1.76M -16.03M -232K -231K -238K -142K -456K -8K -61K 29K 29K
Common Stock Repurchased
-318K -10.57M -242K -431K -544K -1.91M -23.98M -2.71M -232K -869K -29.06M -34.7M -10.58M -494K -688K n/a -39K -513K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-2.32M -11.17M 51K n/a -544K -1.68M -15M n/a 3K n/a -316K -522K -433K -478K -687K -2.9M -5K -469K
Financial Cash Flow
-2.64M -11.17M -327K -567K -1.15M -2.81M -25.95M -4.47M -16.26M -1.1M -29.59M -35.46M -11.15M -934K 13.15M -2.99M 27.88M 47.35M
Net Cash Flow
20.6M 12.14M -2.9M -6.93M 10.43M -42.8M 13.4M 25.73M -7.82M -13.33M -89.26M 29.99M -214.29M 188.18M -49.98M 114.42M -51M 64.03M
Free Cash Flow
-37M -9.15M 21.24M -35.05M -8.66M 3.21M 11.83M 5.32M -2.41M -9.94M 38.48M 15.34M 7.87M 173.05M 71.07M 148.8M 73.18M 221.69M